Table 1 Characteristics of ANRS12174 trial participants who subsequently enrolled in the M&S study by treatment group (N = 553).

From: Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life

 

LPV/r

(n = 274)

3TC

(n = 279)

P value

Mother’s characteristics at randomization (day 7)

Age (years)

28.2 (24.6;32.6)

27.8 (23.2;31.5)

0.12

Parity

3 (2;4)

2(1;4)

0.08

Pre-delivery CD4 counts (cells per uL)

520 (425;654)

517 (441;667)

0.26

Undetectable plasma HIV-1 RNA

123 (45.6)‡

132 (48.5)¤¤

0.49

WHO stage

0.83

 1

264 (96.4%)

266 (95.3%)

 

 2

10 (3.6%)

12 (4.3%)

 

 3

0

1 (0.4%)

 

Maternal PMTCT regimen

 During pregnancy

264 (96.3%)

265 (95.0%)

0.43

 During labour

266 (97.1%)

273 (97.8%)

0.56

 PMTCT treatment duration (weeks)

9 (6;12)

10 (6;12)

0.44

Infant characteristics at randomization (day 7)

Sex

  

0.25

 Male

130 (47.4%)

146 (52.3%)

 

 Female

144 (52.6%)

133 (47.7%)

 

Birthweight (g)

3000 (2800;3400)

3100 (2800;3330)

0.87

Infant characteristics at final (week 50) trial visit

Breastfeeding duration (weeks)

40.7 (33.2;44.9)†

41.0 (34.9;45.6)

0.20

Study treatment duration (weeks)

42.4 (33.4;47.4)

44.1 (36.9;48.9)

0.04

Weight (kg)

8.2 (7.5;9.1)

8.5 (7.7;9.2)¤¤

0.04

Lenght (cm)

71.4 (69.9;73.5)+

72.0 (70.2;73.5)++

0.09

WAZ

− 0.82 (− 1.70;0.01)µ

− 0.72 (− 1.59;0.30)¤¤

0.08

LAZ

− 1.10 (− 1.83;− 0.32)+

− 0.97 (− 1.64;− 0.23)++

0.25

WLZ

− 0.48 (− 1.30;0.46)µ

− 0.27 (− 1.13;0.51)µµ

0.15

Underweight (WAZ < − 2)

43 (19.1%)¤

37 (16.2%)¤¤

0.41

Stunting (HAZ < − 2)

49 (21.6%) +

35 (15.0%)++

0.07

Wasting (WLZ < − 2)

23 (10.2%)µ

25 (11.0%)µµ

0.80

Caregiver/household characteristics at M&S follow-up study

The mother has died

11 (4.0%)

7 (2.5%)

0.32

Mother’s BMI

24.7 (21.4;29.7)£

23.7 (20.9;29.4)££

0.21

The mother is taking HIV ART

163 (69.1%)¥

173 (68.7%)#

0.92

Caregiver’s education (highest grade)

 None

39 (14.2%)

27 (9.7%)

0.10

 Any primary

102 (37.2%)

94 (33.7%)

 

 Any secondary

133 (48.6%)

158 (56.6%)

 

The caregiver can read

221 (80.7%)

239 (85.7%)

0.12

The caregiver can write

219 (79.9%)

241 (86.4%)

0.04

Household socioeconomic score (quintiles)

 1 (poorest)

58 (21.2%)

53 (19.0%)

0.78

 2

51 (18.6%)

59 (21.1%)

 

 3

51 (18.6%)

60 (21.5%)

 

 4

58 (21.2%)

53 (19.0%)

 

 5 (least poor)

56 (20.4%)

54 (19.3%)

 

Number of adults living in household

2 (2;3)

2 (2;3)

0.71

Number of children (5–18 years) living in household

2 (2;3)

2 (1;3)

0.67

Number of children (< 5 years) living in household

 0

160 (58.4%)

130 (46.6%)

 < 0.001

 1

84 (30.7%)

128 (45.9%)

 

  ≥ 2

30 (10.9%)

21 (7.5%)

 

Child’s characteristics at M&S follow-up study

Age (years)

 5

100 (36.5%)

111 (39.8%)

0.65

 6

160 (58.4%)

152 (54.5%)

 

 7

14 (5.1%)

16 (5.7%)

 

School attendance of the child

 None

53 (19.3%)

48 (17.2%)

0.20

 Ever attended kindergarten or primary

147 (53.7%)

136 (48.8%)

 

 Attended both kindergarten and primary

74 (27.0%)

95 (34%)

 
  1. LPV/r lopinavir-ritonavir, 3TC lamivudine, PMTCT prevention of mother to child transmission, WAZ weight-for-age Z-score, LAZ length-for-age Z-score, WLZ weight-for-length Z-score, BMI body mass index.
  2. 2 Missing data. 4 Missing data. ¤¤7 Missing data. ££29 Missing data. #27 Missing data. ¥¥30 Missing data. ¥38 Missing data. £39 Missing data. ++46 Missing data. +47 Missing data. ¤48 Missing data. µ49 Missing data. ¤¤50 Missing data. µµ52 Missing data.